Prognostic utility of tumor-infiltrating lymphocytes in residual tumor after neoadjuvant chemotherapy with trastuzumab for HER2-positive breast cancer
Kurozumi, Sasagu, Inoue, Kenichi, Matsumoto, Hiroshi, Fujii, Takaaki, Horiguchi, Jun, Oyama, Tetsunari, Kurosumi, Masafumi, Shirabe, KenVolume:
9
Journal:
Scientific Reports
DOI:
10.1038/s41598-018-38272-1
Date:
December, 2019
File:
PDF, 2.04 MB
2019